AAV VASC
Alternative Names: AAV-VASCLatest Information Update: 21 Oct 2024
At a glance
- Originator Latus Bio
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research De Vivo disease; Lysosomal storage diseases
Most Recent Events
- 25 Sep 2024 Early research in De Vivo disease in USA (IV) (Latus Bio pipeline, September 2024)
- 25 Sep 2024 Early research in Lysosomal storage diseases in USA (IV) (Latus Bio pipeline, September 2024)